Randomized controlled trial of contingency management for stimulant use in community mental health patients with serious mental illness

American Journal of Psychiatry

Volumn 170, Issue 1, 2013, Pages 94-101

  McDonell, Michael G ^a   Srebnik, Debra ^a   Angelo, Frank ^a   McPherson, Sterling ^a   Lowe, Jessica M ^a   Sugar, Andrea ^a   Short, Robert A ^a   Roll, John M ^a   Ries, Richard K ^a  

^a not available ^*

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; CANNABIS; CENTRAL STIMULANT AGENT; COCAINE; METHAMPHETAMINE; OPIATE;

ADULT; ALCOHOL ABUSE; ARTICLE; COMMUNITY MENTAL HEALTH; CONTINGENCY MANAGEMENT; CONTROLLED STUDY; DRUG DEPENDENCE; DRUG SCREENING; FEMALE; HEALTH CARE UTILIZATION; HOSPITAL ADMISSION; HUMAN; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; RANDOMIZED CONTROLLED TRIAL; REINFORCEMENT; REWARD; SELF REPORT;

EID: 84872054022     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2012.11121831     Document Type: Article

References (44)

1. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, Goodwin FK: Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area (ECA) Study. JAMA 1990; 264:2511-2518
2. RachBeisel J, Scott J, Dixon L: Co-occurring severe mental illness and substance use disorders: a review of recent research. Psychiatr Serv 1999; 50:1427-1434
3. Bennett ME, Bellack AS, Gearon JS: Treating substance abuse in schizophrenia: an initial report. J Subst Abuse Treat 2001; 20:163-175
4. Galanter M, Dermatis H, Egelko S, De Leon G: Homelessness and mental illness in a professional- and peer-led cocaine treatment clinic. Psychiatr Serv 1998; 49:533-535
5. Haywood TW, Kravitz HM, Grossman LS, Cavanaugh JL Jr, Davis JM, Lewis DA: Predicting the "revolving door" phenomenon among patients with schizophrenic, schizoaffective, and affective disorders. Am J Psychiatry 1995; 152:856-861
6. Bartels SJ, Teague GB, Drake RE, Clark RE, Bush PW, Noordsy DL: Substance abuse in schizophrenia: service utilization and costs. J Nerv Ment Dis 1993; 181:227-232
7. Abram KM, Teplin LA: Co-occurring disorders among mentally ill jail detainees: implications for public policy. Am Psychol 1991; 46:1036-1045
8. Watkins KE, Burnam AB, Kung FY, Paddock S: A national survey of care for persons with co-occurring mental and substance use disorders. Psychiatr Serv 2001; 52:1062-1068
9. Epstein JF, Hourani LL, Heller DC: Predictors of treatment receipt among adults with a drug use disorder. Am J Drug Alcohol Abuse 2004; 30:841-869
10. Barrowclough C, Haddock G, Wykes T, Beardmore R, Conrod P, Craig T, Davies L, Dunn G, Eisner E, Lewis S, Moring J, Steel C, Tarrier N: Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial. BMJ 2010; 341:c6325
11. Baker A, Bucci S, Lewin TJ, Kay-Lambkin F, Constable PM, Carr VJ: Cognitive-behavioural therapy for substance use disorders in people with psychotic disorders: randomised controlled trial. Br J Psychiatry 2006; 188:439-448
12. Weiss RD, Griffin ML, Jaffee WB, Bender RE, Graff FS, Gallop RJ, Fitzmaurice GMA: A "community-friendly " version of integrated group therapy for patients with bipolar disorder and substance dependence: a randomized controlled trial. Drug Alcohol Depend 2009; 104:212-219
13. Drake RE, McHugo GJ, Clark RE, Teague GB, Xie H, Miles K, Ackerson TH: Assertive community treatment for patients with co-occurring severe mental illness and substance use disorder: a clinical trial. Am J Orthopsychiatry 1998; 68:201-215
14. Bellack AS, Bennett ME, Gearon JS, Brown CH, Yang Y: A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness. Arch Gen Psychiatry 2006; 63:426-432
15. Drake RE, O'Neal EL, Wallach MA: A systematic review of psychosocial research on psychosocial interventions for people with co-occurring severe mental and substance use disorders. J Subst Abuse Treat 2008; 34:123-138
16. McFarland BH, Gabriel RM: Datapoints: service availability for persons with co-occurring conditions. Psychiatr Serv 2004; 55:978
17. Wakefield PA, Randall GE, Richards DA: Identifying barriers to mental health system improvements: an examination of community participation in assertive community treatment programs. Int J Ment Health Syst 2011; 5:27
18. Brunette MF, Asher D, Whitley R, Lutz WJ, Wieder BL, Jones AM, McHugo GJ: Implementation of integrated dual disorders treatment: a qualitative analysis of facilitators and barriers. Psychiatr Serv 2008; 59:989-995
19. Dutra L, Stathopoulou G, Basden SL, Leyro TM, Powers MB, Otto MWCIN: A meta-analytic review of psychosocial interventions for substance use disorders. Am J Psychiatry 2008; 165:179-187
20. Petry NM, Peirce JM, Stitzer ML, Blaine J, Roll JM, Cohen A, Obert J, Killeen T, Saladin ME, Cowell M, Kirby KC, Sterling R, Royer-Malvestuto C, Hamilton J, Booth RE, Macdonald M, Liebert M, Rader L, Burns R, DiMaria J, Copersino M, Stabile PQ, Kolodner K, Li R: Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study. Arch Gen Psychiatry 2005; 62:1148-1156
21. Sigmon SC, Stitzer ML: Use of a low-cost incentive intervention to improve counseling attendance among methadone-maintained patients. J Subst Abuse Treat 2005; 29:253-258
22. Rawson RA, McCann MJ, Flammino F, Shoptaw S, Miotto K, Reiber C, Ling W: A comparison of contingency management and cognitive-behavioral approaches for stimulant-dependent individuals. Addiction 2006; 101:267-274
23. Rawson RA, Huber A, McCann M, Shoptaw S, Farabee D, Reiber C, Ling W: A comparison of contingency management and cognitive-behavioral approaches during methadone maintenance treatment for cocaine dependence. Arch Gen Psychiatry 2002; 59:817-824
24. Roll JM, Chermack ST, Chudzynski JE: Investigating the use of contingency management in the treatment of cocaine abuse among individuals with schizophrenia: a feasibility study. Psychiatry Res 2004; 125:61-64
25. Ries RK, Dyck DG, Short R, Srebnik D, Fisher A, Comtois KA: Outcomes of managing disability benefits among patients with substance dependence and severe mental illness. Psychiatr Serv 2004; 55:445-447
26. Lichlyter B, Purdon S, Tibbo P: Predictors of psychosis severity in individuals with primary stimulant addictions. Addict Behav 2011; 36:137-139
27. Kosten T, Oliveto A, Feingold A, Poling J, Sevarino K, McCance-Katz E, Stine S, Gonzalez G, Gonsai K: Desipramine and contingency management for cocaine and opiate dependence in buprenorphine maintained patients. Drug Alcohol Depend 2003; 70:315-325
28. Stout RL, Wirtz PW, Carbonari JP, Del Boca FK: Ensuring balanced distribution of prognostic factors in treatment outcome research. J Stud Alcohol Suppl 1994; 12:70-75
29. McLellan AT, Luborsky L, Woody GE, O'Brien CP: An improved diagnostic evaluation instrument for substance abuse patients: the Addiction Severity Index. J Nerv Ment Dis 1980; 168:26-33
30. Derogatis LR, Melisaratos N: The Brief Symptom Inventory: an introductory report. Psychol Med 1983; 13:595-605
31. Kay SR, Fiszbein A, Opler LA: The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 1987; 13:261-276
32. Darke S, Hall W, Heather N, Ward J, Wodak A: The reliability and validity of a scale to measure HIV risk-taking behaviour among intravenous drug users. AIDS 1991; 5:181-185
33. Peirce JM, Petry NM, Stitzer ML, Blaine J, Kellogg S, Satterfield F, Schwartz M, Krasnansky J, Pencer E, Silva-Vazquez L, Kirby KC, Royer-Malvestuto C, Roll JM, Cohen A, Copersino ML, Kolodner K, Li R: Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study. Arch Gen Psychiatry 2006; 63:201-208
34. Zeger SL, Liang KY, Albert PS: Models for longitudinal data: a generalized estimating equation approach. Biometrics 1988; 44:1049-1060
35. Schafer JL, Graham JW: Missing data: our view of the state of the art. Psychol Methods 2002; 7:147-177
36. Enders CK: Missing not at random models for latent growth curve analyses. Psychol Methods 2011; 16:1-16
37. Muthén B, Asparouhov T, Hunter AM, Leuchter AF: Growth modeling with nonignorable dropout: alternative analyses of the STAR*D antidepressant trial. Psychol Methods 2011; 16:17-33
38. Stein MD, Solomon DA, Herman DS, Anthony JL, Ramsey SE, Anderson BJ, Miller IW: Pharmacotherapy plus psychotherapy for treatment of depression in active injection drug users. Arch Gen Psychiatry 2004; 61:152-159
39. Lapham SC, Stout R, Laxton G, Skipper BJ: Persistence of addictive disorders in a first-offender driving while impaired population. Arch Gen Psychiatry 2011; 68:1151-1157
40. Barry D, Weinstock J, Petry NM: Ethnic differences in HIV risk behaviors among methadone-maintained women receiving contingency management for cocaine use disorders. Drug Alcohol Depend 2008; 98:144-153
41. Donlin WD, Knealing TW, Needham M, Wong CJ, Silverman K: Attendance rates in a workplace predict subsequent outcome of employment-based reinforcement of cocaine abstinence in methadone patients. J Appl Behav Anal 2008; 41:499-516
42. Milby JB, Schumacher JE, Wallace D, Freedman MJ, Vuchinich RE: To house or not to house: the effects of providing housing to homeless substance abusers in treatment. Am J Public Health 2005; 95:1259-1265
43. Kirby KC, Benishek LA, Dugosh KL, Kerwin ME: Substance abuse treatment providers' beliefs and objections regarding contingency management: implications for dissemination. Drug Alcohol Depend 2006; 85:19-27
44. Veterans Health Administration: VHA Programs for Veterans With Substance Use Disorders (SUD). Washington, DC, Department of Veterans Affairs, 2011